Allergies News and Research

Latest Allergies News and Research

No link between cat ownership and asthma flare-ups in children

A study of over 30,000 children reveals no link between cat exposure and asthma outcomes, challenging previous concerns about pet ownership and asthma control.

12 Jun 2026

Living with cats does not worsen childhood asthma outcomes

Children with asthma and allergies who live with one or more cats do not experience worse asthma outcomes than children without cats at home.

10 Jun 2026

Study finds indoor cats do not trigger child asthma flares

Asthma is the most common chronic disease and one of the main causes of hospitalization among children. The Global Asthma Network has estimated that its global prevalence is 9.1% for children and 11.0% for adolescents, but this percentage varies greatly between countries, regions, and environments.

10 Jun 2026

Experimental two‑in‑one vaccine shows success in human LASSARAB trial

Researchers from Thomas Jefferson University and the University of Maryland School of Medicine have reported encouraging results from the first human clinical trial of LASSARAB, an experimental vaccine designed to protect against Lassa fever and rabies in a single formulation.

9 Jun 2026

$3.8 million grant funds study on early lung immune responses to tuberculosis

A University of Minnesota Medical School research team was awarded a 5-year, $3.8 million grant from the National Institute of Allergy and Infectious Diseases to study early immune responses in the lung and how they influence tuberculosis infection outcomes.

8 Jun 2026

Early egg introduction reduces childhood allergy rates in Australia

Australian guidelines recommending egg be introduced into a child's diet in the first year of life has seen the number of children with egg allergy drop by 17 per cent, researchers have found.

8 Jun 2026

Repurposed cancer therapy enables successful kidney transplantation

A pioneering clinical trial has successfully enabled three patients with end-stage kidney disease to receive previously improbable kidney transplants.

4 Jun 2026

Novel CAR T treatment makes previously impossible kidney transplants possible

A pioneering clinical trial has successfully enabled two patients with end-stage kidney disease to receive previously improbable kidney transplants.

3 Jun 2026

GLP-1 therapy linked to slower biological aging processes

Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease.

2 Jun 2026

Gladstone receives NIAID grant to establish the Center for PhAIge Therapy

When a bacterial infection stops responding to antibiotics, doctors have few options to treat it. Phages-viruses that naturally infect and kill bacteria-have long intrigued clinicians as a potential weapon against these infections.

2 Jun 2026

Cross-reactive T cells target measles and dangerous Nipah viruses

T cells are some of the immune system's most important warriors. They can stop tumor growth and even fight off severe infections.

2 Jun 2026

Review explores diagnosis and management of perioperative anaphylaxis during anesthesia

Perioperative anaphylaxis is a rare, life‑threatening condition during anesthesia. The unique setting – multiple drugs, patient draping, and altered physiology – causes higher mortality than anaphylaxis elsewhere.

29 May 2026

PET microplastics remain in lungs and worsen respiratory tract inflammation

Microplastics (MP) are the subject of intensive medical research, but little is yet known about their effects on the immune system.

29 May 2026

True toll of long COVID may be double that of current estimates, research shows

The true toll of long COVID may be double that of current estimates and hidden from current surveillance systems that rely on capturing diagnostic codes, according to new research led by Mass General Brigham.

27 May 2026

Silica nanoparticles dampen early allergy signals in mouse mast cells

This in vitro study found that negatively charged SiO2 nanoparticles suppressed antigen-induced degranulation and activation-marker changes in IgE-sensitized mouse bone marrow-derived mast cells. By contrast, mTiO2 nanoparticles showed cytotoxic and pro-inflammatory effects, including enhanced DNP-induced IL-6 release, suggesting nanoparticle composition can shape early allergic immune responses.

24 May 2026

Specialized care helps child thrive despite chronic swallowing disorder

Today, 11-year-old Logan Fitzpatrick of Malverne, New York, spends his time playing baseball, practicing tae kwon do, painting, and cheering on the Mets and the Islanders.

22 May 2026

New oral antiviral drug candidate targets measles and Croup syndrome

A new oral antiviral drug candidate has been developed for the treatment of diseases caused by orthoparamyxoviruses, such as measles and Croup syndrome, according to a study published by researchers in the Center for Translational Antiviral Research at Georgia State University.

22 May 2026